Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ironwood Pharmaceuti (IRWD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,106,265
  • Shares Outstanding, K 154,645
  • Annual Sales, $ 346,640 K
  • Annual Income, $ -282,370 K
  • 60-Month Beta 1.92
  • Price/Sales 6.29
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.12
  • Number of Estimates 6
  • High Estimate 0.10
  • Low Estimate -0.27
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +55.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.93 +6.34%
on 03/07/19
15.09 -8.88%
on 03/04/19
-0.76 (-5.24%)
since 02/25/19
3-Month
9.11 +50.93%
on 12/26/18
15.21 -9.60%
on 02/15/19
+4.44 (+47.69%)
since 12/24/18
52-Week
9.07 +51.60%
on 12/24/18
21.20 -35.14%
on 07/13/18
-1.32 (-8.76%)
since 03/23/18

Most Recent Stories

More News
Ironwood Pharmac Has Returned 17.5% Since SmarTrend Recommendation (IRWD)

SmarTrend identified an Uptrend for Ironwood Pharmac (NASDAQ:IRWD) on January 8th, 2019 at $11.75. In approximately 2 months, Ironwood Pharmac has returned 17.53% as of today's recent price of $13.81....

IRWD : 13.75 (+0.95%)
Why Is Ironwood (IRWD) Down 0.4% Since Last Earnings Report?

Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IRWD : 13.75 (+0.95%)
Ironwood Announces Effectiveness of Cyclerion Form 10 Registration Statement

--- Separation completion expected April 1, 2019 -

IRWD : 13.75 (+0.95%)
Ironwood Pharmac Shares Up 17.5% Since SmarTrend's Buy Recommendation (IRWD)

SmarTrend identified an Uptrend for Ironwood Pharmac (NASDAQ:IRWD) on January 8th, 2019 at $11.75. In approximately 2 months, Ironwood Pharmac has returned 17.53% as of today's recent price of $13.81....

IRWD : 13.75 (+0.95%)
Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference

Ironwood Pharmaceuticals, Inc.(NASDAQ: IRWD) will present a corporate update at the Barclays Global Healthcare Conference on Thursday, March 14, 2019 at 2:35 p.m. Eastern Time at The...

IRWD : 13.75 (+0.95%)
Ironwood Pharmaceuticals to Present at Cowen Health Care Conference

Ironwood Pharmaceuticals, Inc.(NASDAQ: IRWD) will present a corporate update at the 39th Annual Cowen Health Care Conference on Monday, March 11, 2019 at 4:10 p.m. Eastern Time at...

IRWD : 13.75 (+0.95%)
Irritable Bowel Syndrome Treatment Market Stand Out as the Biggest Contributor to Global Growth 2019-2028

The impactful research study of the which represents magnitude, position, and prediction of 2019-2028 market. This report provides detailed and useful information about Irritable Bowel Syndrome Treatment...

VRX.TO : 30.80 (-3.33%)
IRWD : 13.75 (+0.95%)
SCMP : 18.05 (+0.28%)
ALPMF : 15.6300 (+1.26%)
NVS : 93.31 (-0.12%)
SGYP : 0.03 (-52.00%)
GSK : 41.21 (-0.10%)
Recent Analysis Shows Yamana Gold, Broadcom Inc., Atlas Air Worldwide, Hawaiian, H&E Equipment Services, and Ironwood Pharmaceuticals Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Yamana Gold Inc. (NYSE:AUY), Broadcom...

AVGO : 292.16 (-0.17%)
IRWD : 13.75 (+0.95%)
AUY : 2.76 (+5.75%)
HA : 24.61 (+0.49%)
HEES : 24.82 (+1.39%)
AAWW : 46.51 (-0.41%)
Uptrend Call Working As Ironwood Pharmac Stock Rises 22.0% (IRWD)

SmarTrend identified an Uptrend for Ironwood Pharmac (NASDAQ:IRWD) on January 8th, 2019 at $11.75. In approximately 2 months, Ironwood Pharmac has returned 22.04% as of today's recent price of $14.34....

IRWD : 13.75 (+0.95%)
Cyclerion, the Planned R&D Spin-off of Ironwood Pharmaceuticals, Secures Commitments of $175 Million in Private Offering

--- Spin-off expected to be completed in early April 2019 -

IRWD : 13.75 (+0.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade IRWD with:

Business Summary

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome...

See More

Key Turning Points

2nd Resistance Point 14.25
1st Resistance Point 14.00
Last Price 13.75
1st Support Level 13.45
2nd Support Level 13.15

See More

52-Week High 21.20
Fibonacci 61.8% 16.57
Fibonacci 50% 15.14
Last Price 13.75
Fibonacci 38.2% 13.70
52-Week Low 9.07

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar